StockWatch
·
Biotechnology: Pharmaceutical Preparations
ESOPMay 22, 2026, 04:31 PM

Ultragenyx Grants 17,567 RSUs to 11 New Non-Executive Officers

AI Summary

Ultragenyx Pharmaceutical Inc. reported the grant of 17,567 restricted stock units (RSUs) of its common stock to 11 newly hired non-executive officers. These awards, approved by the compensation committee, were granted on May 16, 2026, under the Ultragenyx Employment Inducement Plan. The RSUs vest over four years, with 25% vesting on each anniversary of the grant date, contingent on continuous employment.

Key Highlights

  • Ultragenyx granted 17,567 restricted stock units (RSUs).
  • Awards were given to 11 newly hired non-executive officers.
  • The grants were made under the Ultragenyx Employment Inducement Plan.
  • The grant date for the RSUs was May 16, 2026.
  • The restricted stock units vest over four years, with 25% vesting annually.